Tamura, Yuichi
,
Kumamaru, Hiraku
Abe, Kohtaro
Satoh, Toru
Miyata, Hiroaki
Ogawa, Aiko
Tanabe, Nobuhiro
Hatano, Masaru
Yao, Atsushi
Tsujino, Ichizo
Fukuda, Keiichi
Kimura, Hiroshi
Kuwana, Masataka
Matsubara, Hiromi
Tatsumi, Koichiro
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP18lk1601003h0001)
Article History
Received: 2 May 2020
Accepted: 4 January 2021
First Online: 14 January 2021
Ethics approval and consent to participate
: This study was approved by the ethics committee of International University of Health and Welfare (Approval #5-19-11), and followed the Declaration of Helsinki and the ethical standards of the responsible committee on human experimentation. All patients provided written informed consent to participate. To access the raw data for this study, the steering committee of Japan PH Registry gave a permission to the statisticians.
: Written informed consent for publication of their clinical details was obtained from all of the patients. A copy of the consent form is available for review by the Editor of the journal.
: All clinical data were obtained from medical records in each active centers. 11The data that support the findings of this study are available from Japan PH Registry (nonprofit organization) but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of Japan PH Registry.
: Dr. Yuichi Tamura received a research grants from Bayer Yakuhin, Nippon Shinyaku Pharma, and Actelion pharmaceuticals Japan.